Mounting evidence suggests safety and efficacy of psychedelic compounds as potential
novel therapeutics in psychiatry. Ketamine has been approved by the Food and Drug …

Rationale A broad reassessment of the potential benefits of psychedelic drugs has led to the
initiation of multiple major clinical trials in an effort to advance their status to become FDA …

Classic psychedelics produce altered states of consciousness that individuals often interpret
as meaningful experiences. Across a number of human studies, when the participant-rated …

Importance Major depressive disorder (MDD) is a substantial public health burden, but
current treatments have limited effectiveness and adherence. Recent evidence suggests that …

Recent clinical trials show that psychedelics such as LSD and psilocybin can be given safely
in controlled conditions, and can cause lasting psychological benefits with one or two …

Introduction: As their name suggests,'psychedelic'(mind-revealing) compounds are thought
to catalyse processes of psychological insight; however, few satisfactory scales exist to …

Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to
highly challenging (eg, fear, grief, and paranoia). These challenging experiences contribute …

Healthful behaviours such as maintaining a balanced diet, being physically active and
refraining from smoking have major impacts on the risk of developing cancer, diabetes …

Survey-based studies suggest naturalistic psychedelic use provides mental health benefits
similar to those observed in clinical trials. The current study sought to confirm these findings …

Psychedelic therapy shows promise as a novel intervention for a wide range of mental
health concerns but its therapeutic action is incompletely understood. In line with …